Log In
BCIQ
Print this Print this
 

Samcyprone

  Manage Alerts
Collapse Summary General Information
Company Hapten Pharmaceuticals LLC
DescriptionGel formulation of diphenylcyclopropenone (DPCP), which initiates a T cell response by altering the expression of multiple genes and miRNAs
Molecular Target
Mechanism of ActionImmune modulation
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/19/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today